Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Another Merck Victory Over Vioxx

Posted by Jane Akre
Wednesday, June 04, 2008 3:04 PM EST
Category: On The Road, Major Medical, Protecting Your Family, In The Workplace
Tags: FDA and Prescription Drugs, Vioxx, Merck, Dangerous Drugs, Drug Products

Merck has another victory in court, this time before the New Jersey Supreme court.  

 

LEARN MORE

 

IMAGE SOURCE : Wikimedia Commons/ Human heart/ author: Dake 

 

Today the New Jersey Supreme Court decided that Vioxx users who want to continue  medical monitoring to determine if they were harmed by the drug, do not have to be compensated by drugmaker, Merck & Co.

The 5-1 ruling means a class-action lawsuit will be dismissed.  Merck’s position is that there is no reason that individuals need to be continuously monitored, four years after the drug was taken off the market.

Many patients who took Vioxx for pain continued consulting with cardiac doctors and with electrocardiogram monitoring. Those individuals will not be eligible for a $4.85 billion settlement by Merck because they did not make a claim for harm, the court said.  

"Thus, we conclude that because plaintiffs cannot satisfy the definition of harm to state a product liability claim under the Product Liability Act, plaintiffs' claim for medical monitoring damages must fail," the court said.

Earlier, a trial court had decided to dismiss the medical monitoring suit. An appellate court disagreed, ruling the original dismissal was premature.

This is just the latest in a string of victories for Merck, which pulled Vioxx from the market in 2004 after it was linked to a doubling in the risk of heart attack and stroke among patients who used the drug for at least 18 months.

Recently, appellate courts in Texas and New Jersey struck down victories for plaintiffs or greatly reduced jury awards.

Three plaintiffs still have outstanding product liability judgments against Merck.

Last November, Merck agreed to end thousands of outstanding injury claims by agreeing to a $4.85 billion settlement.  At the time, more than 26,000 lawsuits were filed by people who had taken Vioxx and claimed they had been harmed.

So far, at least 45,000 individuals claim they are eligible to share in the settlement. #


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes